Andrews Nancy C
SEC insider (Form 3/4/5 filer). CIK 0001804999. Director at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) and 1 other issuer. 8 reported Form 4/5 transactions since Sep 2024; latest on Aug 18, 2026. Located in WILMINGTON, MA.
Companies Andrews Nancy C has filed insider reports for
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL): Director
- Maze Therapeutics, Inc. (MAZE): Director
Andrews Nancy C
CIK: 0001804999
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Aug 18, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
ExerciseDirect573 shares at avg. $164.30$94K - Aug 18, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
SaleDirect573 shares at avg. $285.24$163K - Jun 8, 2026MAZE
Maze Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
18K shares- - May 12, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
GiftDirect4K shares- - May 12, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
GiftIndirect4K shares- - May 8, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
AwardDirect1.4K shares at avg. $177.62$255K - Sep 22, 2025MAZE
Maze Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
18K shares- - May 21, 2025CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
AwardDirect946 shares at avg. $134.98$128K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 18, 2026 |  CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Exercise | 573 | $164.30 | $94,144 | Direct |
| Aug 18, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Sale | 573 | $285.24 | $163,443 | Direct |
| Jun 8, 2026 |  MAZE Maze Therapeutics, Inc. | Award Stock Option (Right to Buy) | 18,000 | - | - | Direct |
| May 12, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Gift | 3,964 | - | $0 | Direct |
| May 12, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Gift | 3,964 | - | $0 | Indirect |
| May 8, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Award | 1,438 | $177.62 | $255,418 | Direct |
| Sep 22, 2025 | MAZE Maze Therapeutics, Inc. | Award Stock Option (Right to Buy) | 18,000 | - | - | Direct |
| May 21, 2025 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Award | 946 | $134.98 | $127,691 | Direct |
1-8 of 8 transactions